Toward Individualized Voxel-Level Dosimetry for Radiopharmaceutical Therapy
Int J Radiat Oncol Biol Phys
.
2021 Mar 15;109(4):902-904.
doi: 10.1016/j.ijrobp.2020.08.026.
Authors
Ying Xiao
1
,
Emilie Roncali
2
,
Robert Hobbs
3
,
Sara St James
4
,
Bryan Bednarz
5
,
Stanley Benedict
6
,
Yuni K Dewaraja
7
,
Eric Frey
3
,
Joseph Grudzinski
8
,
George Sgouros
3
,
Jeffrey C Buchsbaum
9
,
Jacek Capala
9
Affiliations
1
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
2
Department of Biomedical Engineering, University of California Davis, Davis, California. Electronic address: eroncali@ucdavis.edu.
3
Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.
4
Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
5
Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin.
6
Department of Radiation Oncology, University of California Davis, Davis, California.
7
Department of Radiology, University of Michigan Ann Arbor, Ann Arbor, Michigan.
8
Department of Radiology, University of Wisconsin-Madison, Madison, Wisconsin.
9
Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
PMID:
33610302
PMCID:
PMC10081021
DOI:
10.1016/j.ijrobp.2020.08.026
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
MeSH terms
Humans
Neoplasms / radiotherapy*
Radiopharmaceuticals / therapeutic use*
Radiotherapy Dosage
Substances
Radiopharmaceuticals
Grants and funding
U10 CA180868/CA/NCI NIH HHS/United States
U24 CA180803/CA/NCI NIH HHS/United States